Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Med Sci Monit ; 22: 3722-3726, 2016 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-27743513

RESUMO

BACKGROUND Prostatitis is a common and refractory urological disease with complicated etiology. Ureaplasma urealyticum (UU) has a close relationship with human urinary tract infection that can induce nonbacterial prostatitis. Tripterygium wilfordii polyglycoside (TWP) is a non-steroidal immune inhibitor that causes significant immune suppression and anti-inflammatory effects. Its role in prostatitis caused by UU has not yet been established. The aim of this study was to investigate the effect of TWP on UU-infected prostatitis in a rat model. MATERIAL AND METHODS UU-infected prostatitis SD model rats were randomly divided into 2 groups: the prostatitis group (model group) and the TWP treatment group (treatment group). At 7 days after treatment, prostate weight, leucocyte count, lecithin corpuscles, UU infection rate, and UU microbe count were compared between the 2 groups. Serum inflammatory cytokines TNF-α was determined by ELISA, and ICAM-1 and NF-κB expression were detected. RESULTS UU infection rate was 80% after modeling. The rat prostate weight and leucocyte count in the model group increased significantly, while lecithin corpuscles decreased. Compared with controls, inflammatory factor TNF-α, ICAM-1, and NF-κB expression were obviously higher (P<0.05). TWP markedly reduced prostate weight and leucocyte count, increased lecithin corpuscles, and decreased UU microbe count and TNF-α, ICAM-1, and NF-κB expression (P<0.05). CONCLUSIONS TWP can inhibit expression of inflammatory factors and may be useful in treating UU-infected prostatitis through reducing UU infection rate.


Assuntos
Glicosídeos/farmacologia , Prostatite/tratamento farmacológico , Tripterygium/química , Infecções por Ureaplasma/tratamento farmacológico , Ureaplasma urealyticum/efeitos dos fármacos , Animais , Citocinas/sangue , Modelos Animais de Doenças , Molécula 1 de Adesão Intercelular/sangue , Masculino , NF-kappa B/sangue , Prostatite/sangue , Prostatite/microbiologia , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Fator de Necrose Tumoral alfa/sangue , Infecções por Ureaplasma/sangue , Infecções por Ureaplasma/microbiologia
2.
Artigo em Chinês | MEDLINE | ID: mdl-20848857

RESUMO

OBJECTIVE: To detect HBV-LP and HBV DNA of the patients with hepatitis B, and to study the sensitive and specificity of HBV-LP detecting and its evaluate on for clinical application. METHODS: The ELISA was used for HBV-LP detecting and RT-PCR for HBV DNA detecting. RESULTS: The sensitive and specificity of HBV-LP and HBV DNA were 64.89%, 99.68%, 60.63% and 100% respectively (P > 0.05); +LR, -LR were 202.78, 60.63, 0.3522 and 0.3937, and there were significance between +LR of the detecting (P < 0.005). CONCLUSION: The sensitive and specificity of HBV-LP and HBV DNA detecting are considerable, +LR of HBV-LP are higher comparing HBV DNA. The HBV-LP is better serology index for detecting replication of HBV DNA.


Assuntos
Replicação do DNA , Ensaio de Imunoadsorção Enzimática/métodos , Vírus da Hepatite B/isolamento & purificação , Hepatite B/diagnóstico , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Proteínas do Envelope Viral/sangue , Adolescente , Adulto , Hepatite B/sangue , Hepatite B/virologia , Vírus da Hepatite B/genética , Humanos , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA